Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
about
Molecular neurobiological clues to the pathogenesis of bipolar disorderGsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium EfficacyApplications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series.The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatmentInnovative approaches to bipolar disorder and its treatmentIP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.Drug Interactions with Lithium: An Update.The management of bipolar disorder.Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence.Neuroprotective Activity of Grape Seed and Skin Extract Against Lithium Exposure Using Proteomic Research.Lithium Pharmacogenetics: Where Do We Stand?Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function.Genomics of Lithium Action and Response.Who are excellent lithium responders and why do they matter?Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors.Cognitive function, treatment response to lithium, and social functioning in Japanese patients with bipolar disorder.Clinically relevant treatment considerations regarding lithium use in bipolar disorder.Lithium reverses mechanical allodynia through a mu opioid-dependent mechanism.Metal Ion Effects on Aβ and Tau Aggregation.Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment.Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.Crowned spiropyran fluoroionophores with a carboxyl moiety for the selective detection of lithium ions.Excitatory and inhibitory synaptic dysfunction in mania: an emerging hypothesis from animal model studies.Protein S-Nitrosylation Controls Glycogen Synthase Kinase 3β Function Independent of its Phosphorylation State.[Bipolar disorder: advances in the prediction of lithium response and development of new therapies using induced pluripotent stem cells].Prediction of response to drug therapy in psychiatric disorders.A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorderAtorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trialImagery-Focused Cognitive Therapy (ImCT) for Mood Instability and Anxiety in a Small Sample of Patients with Bipolar Disorder: a Pilot Clinical Audit
P2860
Q26799513-06214F17-8307-4383-9BE6-0CC7494F0EF6Q28078551-18013BD5-517D-45D4-9422-804AA62CC539Q28597251-BDDA2CF0-F0A4-46D3-8A1D-FA6485F6043FQ33593061-A06E0F63-7E34-4826-8541-76C3545345C9Q36851161-7C67069E-824A-4C01-9596-2D947B38F116Q37650454-4DA97477-6E30-4D16-8B92-920F5AABC9C6Q37710652-1F407A16-E7CA-402D-B0FD-094D0481BE73Q38724876-A5C676A7-7DBC-45D8-99CA-DAA0C5EFA123Q38758442-16FB84CE-724C-4F8B-816A-14D6E776CAACQ38767618-DEAE63B5-D4B2-4930-B39F-A6550048E9C1Q38809416-4D0930CC-61F3-42F2-9339-3FAD2C27BD23Q38891987-B91DBB05-3776-4702-9DE0-055C41612628Q38955537-CC1F212C-2225-48CC-AF71-E3CE55F4459FQ39379034-40992C2B-45FB-48CA-8312-48247885D2B3Q39390032-398A90CD-CBF6-4C60-AAFB-94A965345ED9Q41658786-540A0046-60CB-4835-833E-FC2988FE795DQ46686779-314626B6-B051-44AE-A607-0055696D3B40Q47380956-90B52F7F-5129-4B55-BC7A-B68CABD887EDQ47673229-735EC83E-5672-4E1A-90F4-12EE2DA065A4Q47753611-E88F5566-4914-4500-8315-807FE487C26CQ47849929-B34C5836-5BCE-4679-B98E-FCFA5E394CDCQ47883269-A9E8B7EE-B965-4C68-AAA0-726631E76363Q49332592-A4388690-4DF5-4736-A4D2-AFD4064CCDF1Q49916344-67D2F347-A1F1-4524-A305-100987CD0BCDQ50948318-7A73001E-FEDE-4451-B02C-4C846C13FECFQ51426974-20774430-E296-4128-B4F8-EFAD37152B66Q52328697-EAB8A663-639B-4FD8-ADB4-3388BD275B84Q52644178-6920D55E-AEDC-407E-A56F-CEC96FE58ACCQ52742772-3AB69594-BCE4-4DEE-BB48-23649BBAEC4BQ55002697-90AC61F4-4325-415E-94E8-EB324F3AC180Q57077038-82ADAA41-E336-4FFC-B167-2C5DD49971EFQ57175763-6A0832FF-3338-4280-94FB-1AA1992E38F6Q57868897-F9A8D09A-60DD-449C-B3FE-C3683DF9DC60
P2860
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@ast
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@en
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@nl
type
label
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@ast
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@en
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@nl
prefLabel
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@ast
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@en
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@nl
P2860
P921
P3181
P356
P1433
P1476
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/MP.2015.4
P407
P577
2015-06-01T00:00:00Z